Nucleic Acid Quantification Methods for Difficult Samples

Thanks to a range of advanced methods, quantifying nucleic acids has become more accessible than ever. Still, challenges persist when working with sample types that are difficult to measure accurately. While researchers aim for consistent, easily quantifiable inputs, some materials are inherently problematic and often unavoidable in molecular studies. Because most lab workflows require precise amounts of DNA or RNA for reliable results, selecting the right quantification method is essential. This article reviews commonly used approaches, explains how they address difficult sample types, and offers practical tips to improve consistency across research applications.

Common problematic sample types

Although any biological sample can present challenges for accurate nucleic acid quantification, certain types are particularly problematic. “Quantifying nucleic acid samples is especially challenging when you’re working with low concentrations, limited volumes, degraded material, or in-process contaminants,” explained the Revvity Molecular Biology Specialist Team. They stressed that reliable analysis of these difficult samples depends on instruments capable of delivering accurate data from minimal sample volumes.

Nish Kumar, Senior Global Product Manager at Bio-Rad Laboratories, highlighted several sample types that often frustrate researchers, including FFPE tissue, cell-free DNA (cfDNA), environmental samples, and low-input biopsies. FFPE and cfDNA are especially challenging due to fragmentation and low yield, while environmental samples frequently contain inhibitors that interfere with amplification. For low-input biopsies, limited starting material raises the risk of sample loss during processing. Kumar emphasized that these issues, such as degradation, low abundance, and contamination, frequently “skew quantification or lead to false negatives.”

Adding to the list, Ben Evans, Technical Services Scientist at Promega, shared that microRNA samples also present unique challenges due to their small size and the need for specialized reverse transcription primers. He further noted that environmental sources like wastewater and soil introduce complex inhibitors such as polysaccharides, humic substances, and other PCR blockers. “In each case, a combination of low yield, short fragment length, and inhibitory co-purified material compromises both optical and enzymatic quantification methods, resulting in inaccurate estimation of usable template,” Evans explained.

Methods for difficult samples

The characteristics and limitations of each sample type play a key role in determining the most appropriate quantification method. For assessing fragment size in samples prone to degradation, Evans recommended using electrophoretic tools such as Agilent’s Bioanalyzer or TapeStation, or a qPCR-based approach like Promega’s ProNex DNA QC Assay for a quick pre-sequencing check. “However, fluorometric dye assays like Promega QuantiFluor dyes are a preferred choice among scientists because unbound dye produces minimal background, yielding an excellent signal-to-noise ratio even in the presence of proteins, phenol, or salts,” Evans emphasized.

Sharing a similar perspective, the Revvity Team explained that fluorometric methods are generally favored over spectrophotometric approaches for quantifying low-input or degraded DNA and RNA, due to their greater sensitivity and specificity. Spectrophotometric methods are less effective at low concentrations, more susceptible to interference from contaminants, and unable to distinguish between single- and double-stranded DNA. In contrast, fluorometric RNA assays can detect concentrations as low as 0.2 ng/µL, making them ideal for low-abundance samples. The Revvity Team added that these assays can be run on instruments like the Victor Nivo plate reader, which supports high-throughput workflows by enabling multi-sample quantification.

For applications requiring even greater precision, Kumar recommended droplet digital PCR (ddPCR), noting its ability to provide absolute quantification and its tolerance to inhibitors in challenging samples. Unlike qPCR, ddPCR does not rely on standard curves and excels at detecting rare variants and short amplicons in fragmented samples such as cfDNA and FFPE tissue. Kumar shared that these advantages are especially pronounced when ddPCR is paired with the QX600 system and optimized reagents. When ddPCR is not available, she emphasized that qPCR remains a reliable alternative, especially when used with contaminant removal, controlled input, and high-efficiency reagents like Bio-Rad’s iScript Reverse Transcription Supermix.

Contaminants, common mistakes, and expert recommendations

Even with the right tools, contamination and user error can still affect results, but careful adjustments can help improve nucleic acid quantification. Kumar highlighted several common missteps, such as using long amplicons in degraded samples when shorter amplicons would be more effective. Another frequent error is failing to check for inhibitors, which is why including an internal amplification control is essential for detecting inhibition. “Lastly, poor sample storage or processing can lead to degradation, so proper storage methods like using aqueous tissue preservation solutions and maintaining a cold chain, along with timely extraction, are essential to preserve sample integrity,” Kumar advised.

Another common issue, Evans noted, is relying exclusively on absorbance readings for low-yield or inhibitor-rich samples. In these cases, he recommended using fluorometric or qPCR methods for more accurate quantification. He also pointed out that ignoring fragmentation is a key oversight, since concentration alone doesn’t reflect a sample’s suitability for downstream applications. In these cases, researchers can use an electropherogram or multiplex PCR to quickly assess fragment length. “Careful sample handling, calibrated pipettes, and inhibitor-aware controls collectively help prevent these issues,” added Evans.

The Revvity Team noted that researchers often equate high yield with high quality, a misconception that can lead to misleading results. “Sample handling, overamplification, and relying solely on sample concentration can lead to inaccurate results,” they emphasized. This is particularly important because contaminants and inhibitors can distort quantification, leading to poor PCR results. To address these issues, the Revvity Team recommended using inhibitor removal kits, incorporating internal spike-in controls, or diluting the sample, with the caveat that dilution may lower nucleic acid yield.

Final thoughts from the field

In addition to selecting the right method, accurate nucleic acid quantification depends on thoughtful decisions made before and after measurement. “When working with challenging samples, the workflow to process and analyze these samples becomes truly important,” shared the Revvity Team. They recommended the BioQule NGS system for low-throughput workflows, noting that it combines nucleic acid isolation, library prep, and fluorescence-based quantification in a single automated process. Users can also load blood or cell samples directly and receive quantitated libraries.

“With challenging samples, it’s valuable to slow down, validate each step, and optimize for specificity and sensitivity,” stated Kumar. She recommended designing short amplicons under 100 bp for fragmented material, assessing sample quality before quantification, and using carrier RNA or DNA to improve yield in low-input workflows. Additionally, Kumar advised validating results with multiple methods, such as ddPCR or capillary electrophoresis, and including replicates and controls to detect variability and artifacts. For very low-input samples, she noted that pre-amplifying targets before qPCR or ddPCR may be beneficial, provided the process is carefully controlled to avoid introducing bias.

Building on these insights, Evans emphasized the importance of upstream decisions in achieving reliable quantification. He advised choosing extraction chemistries suited to the specific sample matrix, as this can improve both yield and downstream accuracy. For downstream PCR applications, using PCR-based quantification provides a more accurate reflection of assay performance. Evans also stressed the value of careful documentation, including lot numbers, elution volumes, and quantification results. “A well-kept notebook is often the fastest route to troubleshooting recurring low-signal problems,” he concluded.